|0.9506||+0.0005||+0.05%||Vol 116.35K||1Y Perf -56.81%|
|Nov 29th, 2023 16:00 DELAYED|
|- -||0.06 6.25%|
|Target Price||8.00||Analyst Rating||Strong Buy 1.00|
|Potential %||741.57||Finscreener Ranking||★★★★★ 68.03|
|Insiders Trans % 3/6/12 mo.||100/67/43||Value Ranking||★★★★★ 75.83|
|Insiders Value % 3/6/12 mo.||100/70/39||Growth Ranking||★★★★★ 79.29|
|Insiders Shares Cnt. % 3/6/12 mo.||100/89/75||Income Ranking||— -|
|Price Range Ratio 52W %||4.66||Earnings Rating||Sell|
|Market Cap||84.50M||Earnings Date||2nd Nov 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-0.22|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||152.58K|
|Avg. Monthly Volume||409.59K|
|Avg. Quarterly Volume||468.81K|
Chimerix Inc. (NASDAQ: CMRX) stock closed at 0.9506 per share at the end of the most recent trading day (a 0.05% change compared to the prior day closing price) with a volume of 116.35K shares and market capitalization of 84.50M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 43 people. Chimerix Inc. CEO is Michael Sherman.
The one-year performance of Chimerix Inc. stock is -56.81%, while year-to-date (YTD) performance is -48.89%. CMRX stock has a five-year performance of -71.11%. Its 52-week range is between 0.88 and 2.395, which gives CMRX stock a 52-week price range ratio of 4.66%
Chimerix Inc. currently has a PE ratio of 1.10, a price-to-book (PB) ratio of 0.60, a price-to-sale (PS) ratio of 5.04, a price to cashflow ratio of -, a PEG ratio of -, a ROA of 75.51%, a ROC of 80.10% and a ROE of 84.75%. The company’s profit margin is -%, its EBITDA margin is -229.90%, and its revenue ttm is $33.01 Million , which makes it $0.37 revenue per share.
Of the last four earnings reports from Chimerix Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.22 for the next earnings report. Chimerix Inc.’s next earnings report date is -.
The consensus rating of Wall Street analysts for Chimerix Inc. is Strong Buy (1), with a target price of $8, which is +741.57% compared to the current price. The earnings rating for Chimerix Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Chimerix Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Chimerix Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 16.45, ATR14 : 0.06, CCI20 : -50.76, Chaikin Money Flow : -0.14, MACD : -0.01, Money Flow Index : 31.03, ROC : -3.46, RSI : 46.51, STOCH (14,3) : 36.89, STOCH RSI : 0.00, UO : 35.91, Williams %R : -63.11), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Chimerix Inc. in the last 12-months were: Andriole Michael (Buy at a value of $58 938), David Jakeman (Sold 6 840 shares of value $9 260 ), Demski Martha (Buy at a value of $19 980), Fred A. Middleton (Buy at a value of $24 152), Middleton Fred (Buy at a value of $62 892)
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.